Bas Trietsch

PhD, Zuid-Holland, Netherlands

Dr. Bas Trietsch, is the CTO and co-founder of MIMETAS. He is co-inventor of the OrganoPlate®, optimized it towards a mass manufacturable product and enabled the establishment of MIMETAS’ production facility. He developed the initial tissue models on the OrganoPlate and continues to support assay development in the OrganoPlate. As CTO he currently drives product development and grows Mimetas' tissue production, HTS based drug discovery and data science capabilities. Bas holds a Ph.D. in biopharmaceutical sciences from Leiden University and co-authored over 50 peer-reviewed publications and patents.

Disclosure information not submitted.

Presentation(s):

• A Novel Microfluidic Device for Modeling an Artery-on-a-Chip and Cardiovascular Diseases

  Monday, February 5, 2024
  11:30 AM – 12:00 PM EST

• Sorafenib and Lenvatinib induce vascular responses in patient derived HCC on-Chip models

  Tuesday, February 6, 2024
  11:30 AM – 12:00 PM EST